United States· US:60687-931_51911920-109b-a9be-e063-6394a90a733f
Bromocriptine Mesylate
A bromocriptine product containing bromocriptine mesylate, registered in United States by American Health Packaging. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Bromocriptine is registered in 9 of 19 countries.
Countries holding a registration under ATC G02CB01 (bromocriptine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Bromocriptine · ATC G02CB01
9 / 19 countries
- Czechiaprice
- Finlandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of bromocriptine costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.54 in Italy to $3.22 in United States — a ×5.9 gap.
- United States: $3.22 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Bromocriptine · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- US United States$3.22 (acquisition cost)
- CH Switzerland$2.09
- IT Italy$0.54
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Bromocriptine Mesylate
- Manufacturer
- American Health Packaging
- Country
- United States (US)
- ATC code
- G02CB01
- ATC class
- Bromocriptine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11606879312130 BLISTER PACK in 1 CARTON (60687-931-21) / 1 TABLET in 1 BLISTER PACK (60687-931-11)
Regulatory notes
Interactions
92 interactions on record for bromocriptine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromocriptine · interactions on record
92 records
- 3 severe
- 87 moderate
- 2 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- LorcaserinA08AA11severe
- PhenylpropanolaminA08AA13severe
- LansoprazoleA02BC03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bromocriptine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBromocriptine 2.5mg tabletsNecessity Supplies Ltd
- CzechiaMEDOCRIPTINEMedochemie Ltd., Limassol
- SwedenParlodel 2,5 mg TablettEbb Medical AB
- PolandBromocornFarmaceutyczna Spółdzielnia Pracy FILOFARM
- FinlandParlodelOrifarm Oy
- SwitzerlandParlodel, TablettenSandoz Pharmaceuticals AG
- NorwayParlodelMeda
- NetherlandsParlodel 2,5 mg, tablettenMedcor Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Belgium · Parlodel
- Bulgaria · Бромокриптин Медокеми
- Cyprus · Medocriptine, Pirodal
- Czechia · Medocriptine
- Germany · Pravidel
- Estonia · Bromocriptin Richter
- Spain · Parlodel
- France · Parlodel
- United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
- Hungary · Bromocriptin Richter
- Italy · Parlodel
- Lithuania · Bromocriptin Richter
- Luxembourg · Pravidel
- Latvia · Bromocriptin Richter
- Malta · Medocriptine
- Netherlands · Parlodel
- Norway · Parlodel
- Poland · Bromocorn
- Portugal · Bromocriptina Generis, Parlodel
- Romania · Brocriptin
- Sweden · Pravidel
- Slovakia · Medocriptine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0e8c0da0-01d7-47bf-bf12-dcce6dc21e0e GET /v1/drugs/0e8c0da0-01d7-47bf-bf12-dcce6dc21e0e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "FFP983J3OD",
"rxcui": "142426",
"inchikey": "NOJMTMIRQRDZMT-GSPXQYRGSA-N",
"display_name": "BROMOCRIPTINE MESYLATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 4
},
"spl_meta": {
"ddd292a5-72af-448f-8b88-cc4fd99ec783": {
"match": "brand_token",
"title": "BROMOCRIPTINE MESYLATE TABLET [AMERICAN HEALTH PACKAGING]",
"spl_version": "1",
"published_date": "2026-05-13"
}
},
"productid": "60687-931_51911920-109b-a9be-e063-6394a90a733f",
"productndc": "60687-931",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "017962",
"products": [
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 2.5MG BASE",
"product_no": "001",
"approval_date": "Approved Prior to Jan 1, 1982"
},
{
"rs": false,
"rld": true,
"te_code": "AB",
"strength": "EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "002",
"approval_date": "Mar 1, 1982"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BROMOCRIPTINE MESYLATE",
"proprietary_name": "Bromocriptine Mesylate",
"active_ingred_unit": "mg/1",
"application_number": "NDA017962",
"marketing_category": "NDA",
"nonproprietary_name": "Bromocriptine Mesylate",
"start_marketing_date": "20260501",
"active_numerator_strength": "2.5"
}See everything about bromocriptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.